R980,00
Fat-Loss Reduced Cravings, Energy Boost, Overall Vitality Boost, Improved Insulin Resistance and Metabolic Health.
R980,00
Out of stock
GLP-1, GIP (Dual Receptor Agonist Peptide) is a lab-made synthetic peptide engineered to simultaneously activate two powerful metabolic receptors: GLP-1 and GIP. It represents the next generation of metabolic research compounds – building on single GLP-1 agonists by adding GIP receptor activation for enhanced appetite control, insulin sensitivity, and fat metabolism. Designed as a once-weekly subcutaneous injection, it has become one of the most effective and widely researched tools for weight management and body-composition studies.
Think of the GLP-1, GIP dual agonist as a ‘metabolic power duo’ in one molecule. It targets two complementary pathways for results that feel smoother and more complete than single agonists.
How it works (super simple):
– GLP-1 receptor activation powerfully reduces appetite, slows gastric emptying, and improves insulin response.
– GIP receptor activation enhances fat metabolism, insulin sensitivity, and energy utilization.
– The dual synergy creates superior hunger control and metabolic efficiency without the extremes of single-pathway compounds.
No official guidelines exist (investigational), so protocols come directly from Phase 3 trials and clinical research use.
Typical dose (once-weekly subcutaneous injection – belly or thigh):
– Start low and titrate: 2.5-5 mg for the first few weeks.
Contact Supregroup for support.
-Dual synergy – the first peptide to combine GLP-1 and GIP for results that feel more natural and powerful than single agonists alone.
– Record holder – delivered some of the highest sustained weight-loss numbers ever seen in metabolic research.
– Appetite control champion – users often describe the hunger reduction as ‘effortless’ compared to older options.
– Muscle-friendly metabolism – helps target fat while supporting lean mass better than many predecessors.
– Once-weekly ease – designed for simple weekly dosing, fitting perfectly into busy research routines.
– Beyond scale – emerging data shows real improvements in energy, mobility, and metabolic health markers.
– Research favorite – with ongoing Phase 3 readouts in 2026, this dual agonist remains one of the most talked-about metabolic tools available.
Weight-loss, Appetite suppression, Reduced cravings, Enhanced energy, Insulin sensitivity.
R750,00
Significant Muscle Growth, Improved Strength & Performance, Fat Loss Support
R650,00
Rapid Antidepressant Effects, Cognitive Enhancement & Memory Support, Neuroprotection, Anti-Anxiety
R480,00
Muscle Growth, Fat Loss, Recovery, Better Sleep, Mood, Anti-Aging, Better Skin Elasticity, Stronger Bones, Improved Energy.
R910,00
Significant Fat Loss, Body Composition, Strength and Muscle Retention, Insulin Sensitivity, Mitochondrial Energy, Longevity, Glucose Control.
R800,00
Lean Muscle Growth, Fat Loss, Improved Body Composition and Metabolism, Faster Recovery and Wound Healing, Better Sleep, Anti-Aging, Skin Elasticity, Bone Density, Ligament and Tendon Strength.
R750,00